| 词条 | Partial agonist |
| 释义 |
In pharmacology, partial agonists are drugs that bind to and activate a given receptor, but have only partial efficacy at the receptor relative to a full agonist. They may also be considered ligands which display both agonistic and antagonistic effects—when both a full agonist and partial agonist are present, the partial agonist actually acts as a competitive antagonist, competing with the full agonist for receptor occupancy and producing a net decrease in the receptor activation observed with the full agonist alone.[1] Clinically, partial agonists can be used to activate receptors to give a desired submaximal response when inadequate amounts of the endogenous ligand are present, or they can reduce the overstimulation of receptors when excess amounts of the endogenous ligand are present.[2] Some currently common drugs that have been classed as partial agonists at particular receptors include buspirone, aripiprazole, buprenorphine, nalmefene and norclozapine. Examples of ligands activating peroxisome proliferator-activated receptor gamma as partial agonists are honokiol and falcarindiol.[3][4] Delta 9-tetrahydrocannabivarin (THCV) is a partial agonist at CB2 receptors and this activity might be implicated in ∆9-THCV-mediated anti-inflammatory effects.[5] See also
References1. ^{{cite book |first1=Norman |last1=Calvey |first2=Norton |last2=Williams | name-list-format = vanc |year=2009 |chapter=Partial agonists |chapterurl=https://books.google.com/books?id=lnRlU12Q4h8C&pg=PA62 |page=62 |title=Principles and Practice of Pharmacology for Anaesthetists |isbn=978-1-4051-9484-6}} {{Pharmacology}}{{pharmacology-stub}}2. ^{{cite journal | vauthors = Zhu BT | title = Mechanistic explanation for the unique pharmacologic properties of receptor partial agonists | journal = Biomedicine & Pharmacotherapy | volume = 59 | issue = 3 | pages = 76–89 | date = April 2005 | pmid = 15795100 | doi = 10.1016/j.biopha.2005.01.010 }} 3. ^{{cite journal | vauthors = Atanasov AG, Wang JN, Gu SP, Bu J, Kramer MP, Baumgartner L, Fakhrudin N, Ladurner A, Malainer C, Vuorinen A, Noha SM, Schwaiger S, Rollinger JM, Schuster D, Stuppner H, Dirsch VM, Heiss EH | title = Honokiol: a non-adipogenic PPARγ agonist from nature | journal = Biochimica et Biophysica Acta | volume = 1830 | issue = 10 | pages = 4813–9 | date = October 2013 | pmid = 23811337 | pmc = 3790966 | doi = 10.1016/j.bbagen.2013.06.021 }} 4. ^{{cite journal | vauthors = Atanasov AG, Blunder M, Fakhrudin N, Liu X, Noha SM, Malainer C, Kramer MP, Cocic A, Kunert O, Schinkovitz A, Heiss EH, Schuster D, Dirsch VM, Bauer R | title = Polyacetylenes from Notopterygium incisum--new selective partial agonists of peroxisome proliferator-activated receptor-gamma | journal = PLoS One | volume = 8 | issue = 4 | pages = e61755 | year = 2013 | pmid = 23630612 | pmc = 3632601 | doi = 10.1371/journal.pone.0061755 | bibcode = 2013PLoSO...861755A }} 5. ^{{Cite web|url=http://insubriaspace.cineca.it/bitstream/10277/269/1/Phd_thesis_bolognini_completa.pdf|title=PHARMACOLOGICAL PROPERTIES OF THE PHYTOCANNABINOIDS ∆9-TETRAHYDROCANNABIVARIN AND CANNABIDIOL - Phd thesis of: Dr. Daniele Bolognini - PDF|last=|first=|date=2010|website=|archive-url=|archive-date=|dead-url=|access-date=}} 1 : Pharmacodynamics |
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。